MARIA WISCOVITCH, M.D.
Pain Medicine (Psychiatry & Neurology) Physician in FAJARDO, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARIA WISCOVITCH, M.D. filed 16,357 Medicare Part D claims in 2023 as a Pain Medicine (Psychiatry & Neurology) Physician in FAJARDO, Puerto Rico, prescribing 93% generic.
- 16K
- Part D claims, 2023
- 93%
- generic prescribing
- $1.4K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARIA WISCOVITCH, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
16,357 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
MARIA WISCOVITCH, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MARIA WISCOVITCH, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Puerto Rico
How Pain Medicine (Psychiatry & Neurology) Physician compares to other specialties among Puerto Rico providers
Pain Medicine (Psychiatry & Neurology) Physician share within Puerto Rico
Pain Medicine (Psychiatry & Neurology) Physician is one of the more visible NUCC categories in Puerto Rico
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pain Medicine (Psychiatry & Neurology) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pain Medicine (Psychiatry & Neurology) Physician ABMS/AOA estimate
Est. board-certified rate (Pain Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pain Medicine (Psychiatry & Neurology) Physician US NPIs
Specialty board-certified rate — Pain Medicine (Psychiatry & Neurology) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARIA WISCOVITCH, M.D. appears in the CMS NPPES registry as a Pain Medicine (Psychiatry & Neurology) Physician provider holding M.D. credentials at CARRETERA 194 CC21 FAJARDO GARDENS, FAJARDO, PR, 00738, with a listed phone of (787) 655-7002. NPI 1316023294 was issued on 10/31/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WISCOVITCH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 16,357 prescription claims written by this provider, covering 1,665 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 0.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pain Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 161 enrolled providers across 39 states and an average of 1,690 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1316023294 |
|---|---|
| Specialty | Pain Medicine (Psychiatry & Neurology) Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 10/31/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARIA WISCOVITCH, M.D.'s current license status, disciplinary history, and board certifications directly with the licensing state's medical board before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARIA WISCOVITCH, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.4K
Largest payer
EMD Serono, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
7% brand-name claims vs 93% generic, on 16,357 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 24,353
- Total Day Supply
- 707,711
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $657K
- Opioid Claims
- 43 (0.3% rate)
Patient Demographics
- Average Patient Age
- 72.3 years
- Avg HCC Risk Score
- 1.92
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 354, 65-74: 529, 75-84: 584, 85+: 198
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARIA WISCOVITCH, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
1,863 claims
- Baclofen
Baclofen
1,044 claims
- Tizanidine Hcl
Tizanidine Hcl
1,035 claims
- Pregabalin
Pregabalin
1,002 claims
- Galantamine Er
Galantamine Er
808 claims
- Donepezil Hcl 709
Donepezil Hcl
709 claims
- Memantine Hcl 655
Memantine Hcl
655 claims
- Diclofenac Sodium 536
Diclofenac Sodium
536 claims
| Drug | Claims |
|---|---|
| Gabapentin | 1,863 |
| Baclofen | 1,044 |
| Tizanidine Hcl | 1,035 |
| Pregabalin | 1,002 |
| Galantamine Er Galantamine Hbr | 808 |
| Donepezil Hcl | 709 |
| Memantine Hcl | 655 |
| Diclofenac Sodium | 536 |
| Memantine Hcl Er Memantine Hcl | 432 |
| Rivastigmine | 427 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pain Medicine (Psychiatry & Neurology) Physician Overview
How MARIA WISCOVITCH, M.D. fits within the Pain Medicine (Psychiatry & Neurology) Physician landscape nationally.
MARIA WISCOVITCH, M.D.'s 16,357 claims are above the specialty average of 1,690.
Nearby Pain Medicine (Psychiatry & Neurology) Physician Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as WISCOVITCH.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Puerto Rico
Frequently Asked Questions
What is MARIA WISCOVITCH, M.D.'s specialty? ▼
How much does MARIA WISCOVITCH, M.D. prescribe under Medicare Part D? ▼
Where is MARIA WISCOVITCH, M.D. located? ▼
What is MARIA WISCOVITCH, M.D.'s NPI number? ▼
Does MARIA WISCOVITCH, M.D. prescribe more brand-name or generic drugs? ▼
Does MARIA WISCOVITCH, M.D. prescribe opioids? ▼
How many Pain Medicine (Psychiatry & Neurology) Physician providers are there in the US? ▼
What drugs does MARIA WISCOVITCH, M.D. prescribe most often? ▼
Does MARIA WISCOVITCH, M.D. accept Medicare? ▼
How can I verify MARIA WISCOVITCH, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology